SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human-Reference-Cited by-同舟云学术

SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human

Published:2020-02-07 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Etienne Floriane,Berthaud Maxime,Nguyen Frédérique,Bernardeau Karine,Maurel Catherine,Bodet-Milin Caroline,Diab Maya,Abadie Jérôme,Gouilleux-Gruart Valérie,Vidal Aurélien,Bourgeois Mickaël,Chouin Nicolas,Ibisch Catherine,Davodeau François

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference37 articles.

1. 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years;Casadei;Cancer Med,2016

2. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma;Morschhauser;J Clin Oncol,2008

3. Zevalin((R)) (ibritumomab tiuxetan): after more than a decade of treatment experience, what have we learned?;Rizzieri;Crit Rev Oncol Hematol,2016

4. Radioimmunotherapy for B-cell non-hodgkin lymphomas;Tomblyn;Cancer Control,2012

5. Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas;Kaminski;J Clin Oncol,2001

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in bismuth utilization for biomedical applications – From a bibliometric perspective;Coordination Chemistry Reviews;2024-10